December 9, 2022

Volume XII, Number 343

Advertisement

December 09, 2022

Subscribe to Latest Legal News and Analysis

December 08, 2022

Subscribe to Latest Legal News and Analysis

December 07, 2022

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date Title Organization
8
Dec
FDA Releases Traceability Final Rule K&L Gates
8
Dec
Like a Steam Locomotive, Rolling Down the Track: Biden Signs Marijuana Research Bill Bradley Arant Boult Cummings LLP
8
Dec
DOJ Weighs in on SAFE Banking Act, Requests “Minor Changes” ArentFox Schiff LLP
8
Dec
FSIS and FDA Continue to Investigate Food-Borne Illnesses Keller and Heckman LLP
8
Dec
USDA Seeks Applications for Grants to Help Rural Businesses Produce and Market Value-Added Products U.S. Department of Agriculture
7
Dec
Materials Available from EPA’s NAMs Conference and CompTox Chemicals Dashboard Training Bergeson & Campbell, P.C.
7
Dec
External Evaluation of FDA’s Human Foods Program Published Keller and Heckman LLP
7
Dec
New Law Eases Federal Restrictions on Medical Marijuana Research and Cultivation ArentFox Schiff LLP
6
Dec
Don’t Let Drugs Bring You Down: The Importance of an Effective Drug Diversion Program Sheppard, Mullin, Richter & Hampton LLP
6
Dec
USDA Receives Petition Requesting Amendment to Import for Personal Consumption Regulation Keller and Heckman LLP
6
Dec
You Say Yes, I Say No: What the Recent State Cannabis Elections Say About the Future of Adult-Use Programs Bradley Arant Boult Cummings LLP
5
Dec
TTB Plans to Issue New Rules for Alcohol Beverage Labels Keller and Heckman LLP
2
Dec
President Biden Signs Law Expanding Research on Cannabis Beveridge & Diamond PC
2
Dec
Proposal to Overhaul Privacy Law Governing Substance Use Disorder Treatment Records Sheppard, Mullin, Richter & Hampton LLP
2
Dec
Kroger “Naturally Flavored” Sparkling Water Federal Class Action Lawsuit Filed Keller and Heckman LLP
1
Dec
Medical Marijuana in Your Suitcase? How One Basketball Player’s Conviction Raises Concerns for Employers Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
1
Dec
FDA Webinar on Food Traceability Rule Keller and Heckman LLP
1
Dec
2022 Midterms and the Future of the Safe Banking Act Bradley Arant Boult Cummings LLP
1
Dec
Medicare Hospital Outpatient Prospective Payment System (HOPPS) and Physician Fee Schedule (PFS) Final Rules Released; What Pharma Needs to Know ArentFox Schiff LLP
1
Dec
Chemical Engineering Trends, Intellectual Property Litigation, & Industry Predictions – Episode 50 [PODCAST] IMS Consulting & Expert Services

Pages

Advertisement
Advertisement
Advertisement